Fulltext

Diagnostics and the neglected tropical diseases roadmap: setting the agenda for 2030

Souza AA 1 , Ducker C 2 , Argaw D 3 , King JD 3 , Solomon AW 3 , Biamonte MA 4 Show all authors , Coler RN 5 , Cruz I 6 , Lejon V 7 , Levecke B 8 , Marchini FK 9 , Marks M 10 , Millet P 11 , Njenga SM 12 , Noordin R 13 , Paulussen R 14 , Sreekumar E 15 , Lammie PJ 1

Affiliations 

  • 1 Neglected Tropical Diseases Support Center, Task Force for Global Health, Atlanta, GA 30030, USA
  • 2 Consultant, World Health Organization, Geneva, Switzerland
  • 3 Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
  • 4 Drugs and Diagnostics for Tropical Diseases, San Diego, CA 92111, USA
  • 5 Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA
  • 6 National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain
  • 7 Institut de Recherche pour le Développement, University of Montpellier, Montpellier, France
  • 8 Department of Virology, Parasitology and Immunology, Ghent University, Faculty of Veterinary Medicine, Salisburylaan 133, B-9820 Merelbeke, Belgium
  • 9 Carlos Chagas Institute, Fiocruz Parana, Curitiba, Parana, Brazil
  • 10 Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK
  • 11 Laboratoire de Parasitologie, Université de Bordeaux, Bordeaux, France
  • 12 Kenya Medical Research Institute, Nairobi, Kenya
  • 13 Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Pengang, Malaysia
  • 14 Mondial Diagnostics, Amsterdam, the Netherlands
  • 15 Molecular Virology Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India
Trans R Soc Trop Med Hyg, 2021 01 28;115(2):129-135.
PMID: 33169166 DOI: 10.1093/trstmh/traa118

Abstract

Accurate and reliable diagnostic tools are an essential requirement for neglected tropical diseases (NTDs) programmes. However, the NTD community has historically underinvested in the development and improvement of diagnostic tools, potentially undermining the successes achieved over the last 2 decades. Recognizing this, the WHO, in its newly released draft roadmap for NTD 2021-2030, has identified diagnostics as one of four priority areas requiring concerted action to reach the 2030 targets. As a result, WHO established a Diagnostics Technical Advisory Group (DTAG) to serve as the collaborative mechanism to drive progress in this area. Here, the purpose and role of the DTAG are described in the context of the challenges facing NTD programmes.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications